tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Co (TKPHF)
:TKPHF
US Market
Advertisement

Takeda Pharmaceutical Co (TKPHF) Ratios

Compare
34 Followers

Takeda Pharmaceutical Co Ratios

TKPHF's free cash flow for Q4 2024 was ¥0.46. For the 2024 fiscal year, TKPHF's free cash flow was decreased by ¥ and operating cash flow was ¥-0.04. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.01 1.11 0.97 1.21 1.53
Quick Ratio
0.52 0.58 0.57 0.81 1.10
Cash Ratio
0.15 0.20 0.21 0.40 0.54
Solvency Ratio
0.12 0.11 0.13 0.11 0.12
Operating Cash Flow Ratio
0.38 0.31 0.39 0.52 0.57
Short-Term Operating Cash Flow Coverage
1.75 1.95 2.88 5.51 45.63
Net Current Asset Value
¥ -4.79T¥ -5.28T¥ -5.21T¥ -4.90T¥ -5.02T
Leverage Ratios
Debt-to-Assets Ratio
0.32 0.32 0.31 0.33 0.36
Debt-to-Equity Ratio
0.65 0.67 0.69 0.76 0.90
Debt-to-Capital Ratio
0.39 0.40 0.41 0.43 0.47
Long-Term Debt-to-Capital Ratio
0.36 0.38 0.39 0.42 0.47
Financial Leverage Ratio
2.05 2.08 2.20 2.32 2.50
Debt Service Coverage Ratio
1.44 1.85 2.21 3.00 3.67
Interest Coverage Ratio
2.10 1.39 2.89 2.77 2.05
Debt to Market Cap
0.65 0.74 0.65 0.79 0.74
Interest Debt Per Share
2.99K 3.19K 2.93K 2.89K 3.13K
Net Debt to EBITDA
3.57 5.01 3.25 2.95 3.73
Profitability Margins
Gross Profit Margin
54.70%66.43%69.11%68.99%68.91%
EBIT Margin
8.71%4.04%12.22%11.91%15.54%
EBITDA Margin
25.25%20.51%29.41%33.15%30.76%
Operating Profit Margin
9.62%5.02%12.18%12.91%15.93%
Pretax Profit Margin
3.85%1.24%9.31%8.48%11.45%
Net Profit Margin
2.36%3.38%7.87%6.45%11.76%
Continuous Operations Profit Margin
2.38%3.38%8.09%6.88%11.76%
Net Income Per EBT
61.12%272.90%84.52%76.03%102.67%
EBT Per EBIT
40.08%24.66%76.47%65.66%71.91%
Return on Assets (ROA)
0.76%0.95%2.27%1.75%2.91%
Return on Equity (ROE)
1.48%1.98%4.99%4.05%7.27%
Return on Capital Employed (ROCE)
3.75%1.67%4.27%4.18%4.57%
Return on Invested Capital (ROIC)
2.23%4.42%3.49%3.11%4.67%
Return on Tangible Assets
2.04%2.66%6.47%4.65%7.57%
Earnings Yield
1.56%2.21%4.70%4.21%6.04%
Efficiency Ratios
Receivables Turnover
6.32 6.11 5.91 4.93 3.93
Payables Turnover
4.36 4.47 4.05 3.74 4.28
Inventory Turnover
1.70 1.18 1.26 1.30 1.32
Fixed Asset Turnover
2.33 2.14 2.38 2.25 2.20
Asset Turnover
0.32 0.28 0.29 0.27 0.25
Working Capital Turnover Ratio
13.66 52.80 22.13 5.14 5.19
Cash Conversion Cycle
188.25 286.63 260.99 257.84 284.30
Days of Sales Outstanding
57.78 59.72 61.78 74.08 92.76
Days of Inventory Outstanding
214.11 308.49 289.42 281.35 276.74
Days of Payables Outstanding
83.64 81.58 90.20 97.59 85.20
Operating Cycle
271.89 368.21 351.20 355.43 369.51
Cash Flow Ratios
Operating Cash Flow Per Share
608.55 457.89 629.69 718.33 647.20
Free Cash Flow Per Share
443.26 150.61 221.33 599.34 495.81
CapEx Per Share
177.76 307.28 408.36 118.99 151.39
Free Cash Flow to Operating Cash Flow
0.73 0.33 0.35 0.83 0.77
Dividend Paid and CapEx Coverage Ratio
1.65 0.93 1.07 2.39 1.94
Capital Expenditure Coverage Ratio
3.42 1.49 1.54 6.04 4.28
Operating Cash Flow Coverage Ratio
0.21 0.15 0.22 0.26 0.22
Operating Cash Flow to Sales Ratio
0.21 0.17 0.24 0.31 0.32
Free Cash Flow Yield
10.17%3.62%5.09%17.13%12.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
65.14 45.16 21.29 23.77 16.55
Price-to-Sales (P/S) Ratio
1.53 1.53 1.68 1.53 1.95
Price-to-Book (P/B) Ratio
1.01 0.89 1.06 0.96 1.20
Price-to-Free Cash Flow (P/FCF) Ratio
9.98 27.62 19.65 5.84 8.04
Price-to-Operating Cash Flow Ratio
7.30 9.08 6.91 4.87 6.16
Price-to-Earnings Growth (PEG) Ratio
-1.36 -0.82 0.55 -0.61 0.02
Price-to-Fair Value
1.01 0.89 1.06 0.96 1.20
Enterprise Value Multiple
9.62 12.45 8.95 7.58 10.06
Enterprise Value
11.03T 10.89T 10.60T 8.96T 9.89T
EV to EBITDA
9.53 12.45 8.95 7.58 10.06
EV to Sales
2.41 2.55 2.63 2.51 3.09
EV to Free Cash Flow
15.73 46.23 30.86 9.57 12.77
EV to Operating Cash Flow
11.46 15.21 10.85 7.98 9.79
Tangible Book Value Per Share
-1.28K -1.54K -1.74K -1.63K -1.77K
Shareholders’ Equity Per Share
4.38K 4.65K 4.09K 3.63K 3.31K
Tax and Other Ratios
Effective Tax Rate
0.38 -1.73 0.15 0.24 -0.03
Revenue Per Share
2.90K 2.73K 2.60K 2.28K 2.05K
Net Income Per Share
68.24 92.09 204.29 147.14 240.72
Tax Burden
0.61 2.73 0.85 0.76 1.03
Interest Burden
0.44 0.31 0.76 0.71 0.74
Research & Development to Revenue
0.16 0.17 0.16 0.15 0.14
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.01 0.02 0.02 0.01 0.01
Income Quality
8.91 4.97 3.08 4.88 2.69
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis